These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
723 related items for PubMed ID: 9920218
21. Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma. Imai C, Yamazaki H, Tanaka Y, Matsunaga M, Numata O, Torigoe K. Pediatr Int; 1999 Apr; 41(2):142-6. PubMed ID: 10221016 [Abstract] [Full Text] [Related]
22. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood. Prehn A, Seger RA, Torresani T, Molinari L, Sennhauser FH. Pediatr Allergy Immunol; 2000 May; 11(2):87-94. PubMed ID: 10893010 [Abstract] [Full Text] [Related]
23. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis. Kristjánsson S, Shimizu T, Strannegård IL, Wennergren G. Pediatr Allergy Immunol; 1994 Nov; 5(4):223-9. PubMed ID: 7894629 [Abstract] [Full Text] [Related]
24. Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Oymar K, Elsayed S, Bjerknes R. Pediatr Allergy Immunol; 1996 Nov; 7(4):180-6. PubMed ID: 9151339 [Abstract] [Full Text] [Related]
25. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Mattes J, Storm van's Gravesande K, Reining U, Alving K, Ihorst G, Henschen M, Kuehr J. Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617 [Abstract] [Full Text] [Related]
26. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity. Fujitaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y. Ann Allergy Asthma Immunol; 2001 Mar; 86(3):323-9. PubMed ID: 11289333 [Abstract] [Full Text] [Related]
27. Eosinophils and eosinophil-derived proteins in children with moderate asthma. Hoekstra MO, Hovenga H, Gerritsen J, Kauffman HF. Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065 [Abstract] [Full Text] [Related]
28. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Vatrella A, Ponticiello A, Parrella R, Romano L, Zofra S, DiLeva A, Bariffi F. Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658 [Abstract] [Full Text] [Related]
29. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Alvarez MJ, Olaguibel JM, García BE, Rodríquez A, Tabar AI, Urbiola E. Allergy; 2000 Apr; 55(4):355-62. PubMed ID: 10782520 [Abstract] [Full Text] [Related]
30. Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough. Labbé A, Aublet-Cuvelier B, Jouaville L, Beaugeon G, Fiani L, Petit I, Ouchchane L, Doly M. Pediatr Pulmonol; 2001 May; 31(5):354-62. PubMed ID: 11340681 [Abstract] [Full Text] [Related]
31. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi E, Favilli T, Vierucci A. J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858 [Abstract] [Full Text] [Related]
32. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G. J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347 [Abstract] [Full Text] [Related]
33. Clinical value of monitoring eosinophil activity in asthma. Koller DY, Herouy Y, Götz M, Hagel E, Urbanek R, Eichler I. Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357 [Abstract] [Full Text] [Related]
34. Manifold significance of serum eosinophil cationic protein in asthmatic children. Zubović I, Rozmanić V, Ahel V, Banac S. Acta Med Croatica; 2002 Nov; 56(2):53-6. PubMed ID: 12596625 [Abstract] [Full Text] [Related]
35. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Lopuhaä CE, Out TA, Jansen HM, Aalberse RC, van der Zee JS. Clin Exp Allergy; 2002 Dec; 32(12):1720-7. PubMed ID: 12653162 [Abstract] [Full Text] [Related]
36. Comparison of basophil histamine release, eosinophil cationic protein and non-specific airway responsiveness between mite-sensitive asthmatic and non-asthmatic children and non-allergic controls. Takeda K, Shibasaki M, Imoto N, Shimakura Y, Takita H. Clin Exp Allergy; 1996 Aug; 26(8):918-25. PubMed ID: 8877157 [Abstract] [Full Text] [Related]
37. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Oddera S, Silvestri M, Balbo A, Jovovich BO, Penna R, Crimi E, Rossi GA. Allergy; 1996 Feb; 51(2):100-7. PubMed ID: 8738515 [Abstract] [Full Text] [Related]
38. Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis. Koller DY, Halmerbauer G, Müller J, Frischer T, Schierl M. Allergy; 1999 Oct; 54(10):1094-9. PubMed ID: 10536888 [Abstract] [Full Text] [Related]
39. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N. Turk J Pediatr; 2009 Oct; 51(5):460-5. PubMed ID: 20112601 [Abstract] [Full Text] [Related]
40. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. Kristjánsson S, Strannegård IL, Strannegård O, Peterson C, Enander I, Wennergren G. J Allergy Clin Immunol; 1996 Jun; 97(6):1179-87. PubMed ID: 8648010 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]